HLA-DR-BINDING ANTIGEN PEPTIDE DERIVED FROM WT1

• 收藏
• 分享

专利权人:

INC.;INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY

发明人:

Haruo SUGIYAMA

申请号：

US13755185

公开号：

US20130243800A1

申请日:

2013.01.31

申请国别(地区):

US

年份:

2013

代理人:

摘要：

The present invention provides a method of treating or preventing cancer, by administering a peptide consisting of 16-25 contiguous amino acids in the amino acid sequence of human WT1 of SEQ ID NO: 1, which has the amino acid sequence of SEQ ID NO: 24, an expression vector having a polynucleotide encoding said peptide or a cell containing the expression vector to a subject in need thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/